$39.895
-0.855[-2.10%]
Last update: 10:14AM Get Real Time Here
Apellis Pharmaceuticals
(NASDAQ:APLS)Apellis Pharmaceuticals Stock (NASDAQ:APLS), Quotes and News Summary
Apellis Pharmaceuticals Stock (NASDAQ: APLS) stock price, news, charts, stock research, profile.
| Open | $40.030 |
| Close | - |
| Volume / Avg. | 136.323K / 1.427M |
| Day Range | 39.580 - 40.630 |
| 52 Wk Range | 19.830 - 94.750 |
| Market Cap | $4.842B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 14.33% |
| Days to Cover | 7.54 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Apellis Pharmaceuticals (APLS) stock?
You can purchase shares of Apellis Pharmaceuticals (NASDAQ: APLS) through any online brokerage.
Who are Apellis Pharmaceuticals's (APLS) competitors?
Other companies in Apellis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Alkermes (NASDAQ:ALKS).
What is the target price for Apellis Pharmaceuticals (APLS) stock?
The latest price target for Apellis Pharmaceuticals (NASDAQ: APLS) was reported by Piper Sandler on Friday, May 31, 2024. The analyst firm set a price target for 46.00 expecting APLS to rise to within 12 months (a possible 15.30% upside). 72 analyst firms have reported ratings in the last year.
Current Stock Price for Apellis Pharmaceuticals (APLS)?
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $39.895 last updated Today at May 31, 2024 at 10:14 AM EDT.
Does Apellis Pharmaceuticals (APLS) pay a dividend?
There are no upcoming dividends for Apellis Pharmaceuticals.
When is Apellis Pharmaceuticals (NASDAQ:APLS) reporting earnings?
Apellis Pharmaceuticals’s Q2 earnings are confirmed for Monday, July 29, 2024.
Is Apellis Pharmaceuticals (APLS) going to split?
There is no upcoming split for Apellis Pharmaceuticals.
What sector and industry does Apellis Pharmaceuticals (APLS) operate in?
Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.